Published in Immunology on November 01, 1965
Nature and mode of action of antilymphocytic antiserum. Proc Natl Acad Sci U S A (1966) 7.56
The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation. Surg Gynecol Obstet (1967) 7.24
Mechanism of eosinophilia. II. Role of the lymphocyte. J Exp Med (1970) 4.34
The preparation and testing of horse antidog and antihuman antilymphoid plasma or serum and its protein fractions. Surg Gynecol Obstet (1967) 3.86
Anti-lymphocytic antibody--a review. Clin Exp Immunol (1967) 2.75
Heterologous antilymphocyte glubulin, histoincompatiblity matching, and human renal homotransplantation. Surg Gynecol Obstet (1968) 2.23
Notes on the preparation and assay of anti-lymphocytic serum for use in mice. Immunology (1968) 1.96
The selective action of antilymphocyte serum on recirculating lymphocytes: a review of the evidence and alternatives. Clin Exp Immunol (1970) 1.76
Renal transplantation in the inbred rat. 3. A study of heterologous anti-thymocyte sera. J Exp Med (1967) 1.57
Anti-lymphocytic antibody and autoimmune disease: a review. Clin Exp Immunol (1969) 1.53
Mode of action of anti-lymphocyte globulin. II. Changes in the lymphoid cell population in rats treated with anti-lymphocyte globulin. Immunology (1968) 1.49
Metastatic spread of human tumour implanted into thymectomized, antithymocyte serum treated hamsters. Br J Cancer (1972) 1.15
The clinical use of antilymphocyte globulin in renal homotransplantation. Transplantation (1967) 1.09
Adoptive transfer of the diseases of New Zealand black mice to normal mouse strains. Clin Exp Immunol (1969) 1.08
Participation of three cell types in the anti-sheep red blood cell response in vitro. Separation of antigen-reactive cells from the precursors of antibody-forming cells. J Exp Med (1971) 1.08
The effect of heterologous anti-lymphocyte serum on lymphocytes of thymus and marrow origin. J Exp Med (1970) 1.04
Thymectomy and renal homotransplantation. Clin Exp Immunol (1970) 0.98
Heterologous antilymphocyte globulin. N Engl J Med (1968) 0.97
Parallel studies on the effect of anti-lymphocytic antibody on cell mediated and humoral antibody responses in the rat. Clin Exp Immunol (1968) 0.92
Use of anti-lymphocyte serum to prolong dog homograft survival. Surg Forum (1966) 0.89
Symposium on immunosuppressive drugs. Attributes of clinically used immunosuppressive drugs: possible future uses of antilymphoid sera. Fed Proc (1967) 0.84
Immunologic response in vitro after thymechtomy in patients with myasthenia gravis. Can Med Assoc J (1976) 0.83
Immunosuppressive and graft-rejecting anti--bodies in heterologous anti-lymphocytic serum. J Exp Med (1971) 0.83
Renal disease in (NZB x NZW)F1 hybrid mice treated with anti-lymphocytic antibody. Clin Exp Immunol (1970) 0.83
Mode of recovery from the effects of heterologous anti-lymphocyte serum. I. Recovery of the immune response. Immunology (1972) 0.77
The immunosuppressive activity of adamantoyl cytarabine. 3. Immunosuppressive specificity in rats. Immunology (1970) 0.75
Synergistic immunosuppressive action of antithymocyte antisera and thymectomy in the human. Clin Exp Immunol (1972) 0.75
Tetanus antitoxin titration by haemagglutination. J Hyg (Lond) (1957) 4.43
EVIDENCE FOR A HUMORAL THYMUS FACTOR RESPONSIBLE FOR THE MATURATION OF IMMUNOLOGICAL FACULTY. Nature (1963) 3.80
EVIDENCE FOR FUNCTION OF THYMIC TISSUE IN DIFFUSION CHAMBERS IMPLANTED IN NEONATALLY THYMECTOMIZED MICE. PRELIMINARY REPORT. J Natl Cancer Inst (1963) 3.23
The thymic origin of the plasma lymphocytosis stimulating factor. Br J Cancer (1956) 2.83
Nucleic acid turnover studies in human leukaemic cells and the function of lymphocytes. Nature (1956) 2.72
Destruction of lymphocytes in vitro by normal serum from common laboratory animals. J Immunol (1961) 1.72
STUDIES OF IMMUNE DESTRUCTION OF LYMPHOID TISSUE. I. LYMPHOCYTOTOXIC EFFECT OF RABBIT-ANTI-RAT-LYMPHOCYTE ANTISERUM. Transplantation (1964) 1.56
IMMUNOLOGIC STATUS OF THYMECTOMIZED ADULT RATS. J Immunol (1964) 1.29
The effect of heterologous anti-lymphocyte serum on lymphocytes of thymus and marrow origin. J Exp Med (1970) 1.04
Studies on the mode of action of heterologous anti-lymphocyte plasma. II. The effect of anti-lymphocyte plasma on lymphocyte counts. Transplantation (1968) 0.97
In vivo antibody production by spleen cells after incubation in vitro with heterologous antilymphocyte plasma. Nature (1968) 0.91
The relationship of lymphopenia production and lymphocyte agglutinating and cytotoxic antibody titers to the immunosuppressive potency of heterologous antilymphocyte plasma. Transplantation (1967) 0.90
Stimulation of tumor growth by the immune response. Int J Cancer (1974) 0.86
Allograft survival prolonged by heterologous spleen cells in 'Millipore' diffusion chambers. Nature (1967) 0.83
Immunosuppressive and graft-rejecting anti--bodies in heterologous anti-lymphocytic serum. J Exp Med (1971) 0.83
Heterologous antilymphocyte serum: a review. Can J Surg (1971) 0.81
Heterologous antilymphocyte serum (ALS) hastens the appearance of methylcholanthrene-induced tumours in mice. Transplantation (1970) 0.81
Immunological studies of women with primary breast carcinoma. Int J Cancer (1975) 0.80
Mode of recovery from the effects of heterologous anti-lymphocyte serum. I. Recovery of the immune response. Immunology (1972) 0.77
Comparative effects of cytotoxic agents on transplanted hematopoietic and antibody-producing cells. J Natl Cancer Inst (1973) 0.77
Studies on the mode of action of heterologous antilymphocyte plasma (ALP). 3. The effects of 6-mercaptopurine and cortisol on the immunosuppressive properties of ALP. Transplantation (1968) 0.76
Comparison of autochthonous and allogeneic breast-tumour cells in tests for lymphocyte immunity to human tumours. Br J Cancer (1977) 0.75
Mode of recovery from the effects of heterologous anti-lymphocyte serum. II. Recovery of the cells involved in antibody production. Immunology (1972) 0.75
Mechanisms of immunosuppression by heterologous anti-lymphocyte serum (ALS) and plasma (ALP). Int Z Klin Pharmakol Ther Toxikol (1970) 0.75
The anti-tumor effect of lymphoid cells placed in Millipore diffusion chambers. Transplantation (1966) 0.75
The in vitro manifestations of cellular and humoral allograft and anti-tumor immunity: no appreciable alteration by previous storage of targe and effector cells in liquid nitrogen. J Reticuloendothel Soc (1976) 0.75
Inactivation of thymus and marrow-derived lymphocytes by heterologous antilymphocyte serum (ALS). Transplant Proc (1971) 0.75
Inhibition of the growth of mouse polyoma tumors by lymph node fragments from specifically immunized rats. Cancer Res (1969) 0.75
Immunosuppressive properties of heterologous antilymphocytic sera prepared against thymocyte soluble fraction. 1. Proc Soc Exp Biol Med (1972) 0.75
Letter: Method for studying functional activity of breast-cancer cells. Lancet (1975) 0.75
The role of the immune response in oncogenesis. In Vitro (1975) 0.75